BaseHealthTM Adds Illumina CTO To Board Of Directors

Redwood City, CA -- BaseHealth, the maker of the integrated health management platform GenophenTM, today announced the addition of Dr. Mostafa Ronaghi to the company’s Board of Directors. Dr. Ronaghi is the current Chief Technology Officer of Illumina, Inc., the leader in next-generation sequencing technologies. He is also a serial life sciences entrepreneur with a [...]

Bruker Wins Two Significant Orders for FT-NIR Spectrometers in China

BILLERICA, Mass.-- Bruker Corporation (NASDAQ: BRKR) today announced that it recently has received two significant orders of TANGO and MATRIX-I FT-NIR (Fourier transform near infrared) spectrometers from leading animal nutrition companies in the People’s Republic of China. The agricultural high-tech company Da Bei Nong Science and Technology Group (DBN), a leading feed and seed products [...]

Horizon Discovery Group plc to Acquire CombinatoRx Service Business and Assets from Zalicus Inc.

Cambridge, UK and Cambridge, Massachusetts, USA –- Horizon Discovery Group plc (LSE: HZD) (“Horizon” or the “Company”), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, today announced it has agreed to acquire the CombinatoRx service business (known as the combination high [...]

Agilent Technologies Introduces New SureDirect Blood PCR Kit

SANTA CLARA, Calif.-– Agilent Technologies Inc. (NYSE: A) today introduced the new SureDirect Blood PCR Kit for amplification of DNA directly from blood and blood derivatives, without the need for nucleic acid extraction and isolation. This kit simplifies the DNA amplification workflow and decreases turn-around time by enabling PCR (polymerase chain reaction) directly from fresh, [...]

BIO-TECHNE ANNOUNCES THE APPOINTMENT OF HAROLD WIENS TO THE BOARD OF DIRECTORS

Minneapolis -- Techne Corporation (NASDAQ:TECH), (d/b/a Bio-Techne) announces that Harold Wiens, a 30+ year veteran of 3M company, has joined the board of Bio-Techne, adding additional seasoned global business experience to a well-established team. Harold graduated from Michigan Technological University with a Bachelor's degree in Mechanical Engineering in 1968. He began working for 3M in [...]

BaseHealthTM Adds Illumina CTO To Board Of Directors

Redwood City, CA -- BaseHealth, the maker of the integrated health management platform GenophenTM, today announced the addition of Dr. Mostafa Ronaghi to the company’s Board of Directors. Dr. Ronaghi is the current Chief Technology Officer of Illumina, Inc., the leader in next-generation sequencing technologies. He is also a serial life sciences entrepreneur with a [...]

Zalicus to Sell cHTS Service Business to Horizon Discovery Group

CAMBRIDGE, Mass.-- Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it has entered into an agreement under which Horizon Discovery Group will acquire its combination High Throughput Screening (cHTS) platform and related assets for $8 million. The cHTS sale is [...]

Emerson opens engineering and services center to enhance support for growing customer base in Thailand and Indo-China

SINGAPORE -- Emerson Process Management today opened a new 2,450-square-meter engineering and services center in Rayong, Thailand, to provide enhanced local support of its growing customer base in Indo-China. “The new facility is a strategic investment to support Emerson’s five-year plan for the region,” commented Sabee Mitra, president of Emerson Process Management Asia Pacific. “The [...]

Eurofins Genomics signs contract to supply oligonucleotides and DNA sequencing to Research Councils

Ebersberg, Germany -- Eurofins Genomics, international market leader in genomic services, has signed a two year contract with the UK Shared Business Services Ltd (UK SBS) formerly RCUK Shared Services Centre Ltd, as one of the preferred suppliers of both oligonucleotides and DNA sequencing on the recently awarded framework contract. The contract builds on the [...]

JOHN D. THOMPSON JOINS TRANSGENOMIC’S BOARD OF DIRECTORS

OMAHA, Neb.-- Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced the appointment of John D. Thompson to its Board of Directors. His appointment was effective May 14, 2014. “John Thompson brings extensive experience in life [...]

Access IBO on Knowledge Center